[Stenting in obstruction of superior vena cava; clinical experience with the self-expanding endovascular prosthesis].
From August 1997 to December 2002, 14 consecutive patients with superior vena cava syndrome with the self-expanding endovascular prosthesis. Diagnoses were adenocarcinoma in 6, small cell carcinoma in 4, squamous cell carcinoma in 1, metastatic lung cancer in 2, and invasive thymoma in 1. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) were measured on their admission and perioperative period. Expecting only 1 patient complete symptomatically relieved within 3 days of stent implantation. Superior vena cava pressure or radial pressure of the stent was sufficient to relieve obstruction. Preoperative ANP level were normal, BNP level were increased. Postoperatively both ANP level and BNP level were slightly increased under intravenous dopamine hydrochloride. Implantation of the self-expanding stent endovascular prosthesis for superior vena cava syndrome provides rapid symptomatic relief and improves the patient's quality of life.
Kanzaki
M
M
Department of Surgery I, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan.
Sakuraba
M
M
Kuwata
H
H
Ikeda
T
T
Oyama
K
K
Mae
M
M
Murasugi
M
M
Miyano
H
H
Wachi
N
N
Kikkawa
T
T
Aoshima
H
H
Onuki
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D009320:Atrial Natriuretic Factor / Q000097:blood*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011379:Prognosis; D019736:Prostheses and Implants; D011788:Quality of Life; D015607:Stents; D013479:Superior Vena Cava Syndrome / Q000503:physiopathology* / Q000601:surgery*
D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor